Literature DB >> 9061504

Effect of an oral calcium load on urinary markers of collagen breakdown.

A Rubinacci1, P Divieti, R M Polo, M Zampino, G Resmini, R Tenni.   

Abstract

Aim of this study was to investigate whether osteoclast activity changes as a consequence of even mild physiological perturbation of plasma calcium as such induced by an oral calcium load. Osteoclast activity was determined indirectly by measuring, in spot urines at two and four hours after oral calcium load, the urinary excretion of hydroxylysylpyridinoline (Pyr), deoxylysylpyridinoline (D-Pyr), hydroxyproline (Hyp) and galactosyl-hydroxylysine (GHyl). The occurrence of the metabolic perturbation of plasma calcium homeostasis was assessed by measuring three indexes: i.e. calcemic response, PTH reduction and calciuric response at times following oral calcium loading. A significant fall of urinary D-Pyr and Pyr followed the perturbation of calcium homeostasis induced by the oral calcium load in two groups of healthy young adult and postmenopausal women. The highest mean percent reduction was observed for D-Pyr and was quantitatively similar in the two groups. Since urinary D-Pyr is the most specific bone resorption marker, it may be inferred that the perturbation of plasma calcium homeostasis induced by an oral calcium load is able to acutely inhibit osteoclast activity. This supports the view that osteoclasts are involved in the short-term error correction of plasma calcium.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9061504     DOI: 10.1007/BF03347874

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  44 in total

1.  'Calcium-activated' intracellular calcium elevation: a novel mechanism of osteoclast regulation.

Authors:  M Zaidi; H K Datta; A Patchell; B Moonga; I MacIntyre
Journal:  Biochem Biophys Res Commun       Date:  1989-09-29       Impact factor: 3.575

Review 2.  Bone and plasma calcium homeostasis.

Authors:  A M Parfitt
Journal:  Bone       Date:  1987       Impact factor: 4.398

3.  Comparison of the biochemical and hormonal acute effects of calcium salts.

Authors:  S Guillemant; J Guillemant; P Duntze
Journal:  Osteoporos Int       Date:  1995-01       Impact factor: 4.507

4.  Effect of calcium supplementation on urinary hydroxyproline in osteoporotic postmenopausal women.

Authors:  M Horowitz; A G Need; J C Philcox; B E Nordin
Journal:  Am J Clin Nutr       Date:  1984-06       Impact factor: 7.045

5.  Short-term effects of calcium carbonate, lactate, and gluconate on the calcium-parathyroid axis in normal elderly men and women.

Authors:  M Goddard; G Young; R Marcus
Journal:  Am J Clin Nutr       Date:  1986-11       Impact factor: 7.045

6.  Control of cytosolic free calcium in rat and chicken osteoclasts. The role of extracellular calcium and calcitonin.

Authors:  A Malgaroli; J Meldolesi; A Z Zallone; A Teti
Journal:  J Biol Chem       Date:  1989-08-25       Impact factor: 5.157

7.  Quantitation of hydroxypyridinium crosslinks in collagen by high-performance liquid chromatography.

Authors:  D R Eyre; T J Koob; K P Van Ness
Journal:  Anal Biochem       Date:  1984-03       Impact factor: 3.365

8.  Urinary bone resorption markers in patients with metabolic bone disorders.

Authors:  T Ohishi; K Kushida; M Takahashi; K Kawana; K Yagi; K Kawakami; K Horiuchi; T Inoue
Journal:  Bone       Date:  1994 Jan-Feb       Impact factor: 4.398

9.  Urinary pyridinium crosslinks of collagen: specific markers of bone resorption in metabolic bone disease.

Authors:  M J Seibel; S P Robins; J P Bilezikian
Journal:  Trends Endocrinol Metab       Date:  1992-09       Impact factor: 12.015

10.  Regulation of parathyroid hormone secretion by plasma calcium in aging rats.

Authors:  J Fox
Journal:  Am J Physiol       Date:  1991-02
View more
  1 in total

1.  Rapid suppression of bone resorption and parathyroid hormone secretion by acute oral administration of calcium in healthy adult men.

Authors:  S Ortolani; A Scotti; R Cherubini
Journal:  J Endocrinol Invest       Date:  2003-04       Impact factor: 4.256

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.